The Company Prepares to Launch a Major Sales Initiative

FLOWER MOUND, TX / ACCESSWIRE / March 3, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstream^TM biopesticide, today announced that it had posted the MiteXstream^TM Efficacy Report published by British Columbia laboratory Botanical Research in Motion (BRIM) at MiteXstream.com.

"The power of MiteXstreamTM has now been validated and sets the stage for our marketing campaign to introduce this revolutionary product worldwide. This BRIM Report coupled with the knowledge base we built over three-plus years of using it allows us to build a powerful sales program," said Fabian Deneault, developer of MiteXstreamTM and President of BBBT. He added, "We encourage a full reading of this report to understand the products' high efficiency and tremendous market potential."

According to market reports, the global market for biopesticides and synthetic pesticides reached $78.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.5% from 2016 to 2021. Black Bird is in the process of assembling a top-notch team of industry professionals to work towards large industrial contracts and potential joint ventures in markets worldwide.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstream^TM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstream^TM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstream^TM Edge: use through the day of harvest without concern for residual "pesticide" violations, including in state cannabis testing. MiteXstream^TM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

Eric Newlan
Vice President
833-223-4204
eric@newlanpllc.com
BlackBirdBiotech.com

SOURCE: Black Bird Biotech, Inc.